Anxiety

Anxiety disorder is a mental ailment that leads to unnecessary anxiety over different activities and events.

What is Anxiety?

Anxiety disorder is a mental ailment that leads to unnecessary anxiety over different activities and events.

What is Generalized Anxiety Disorder?

Sticking it to Anxiety: The Science Behind Anti-Anxiety Patches

Reducing Chest Pain Caused by Anxiety

Genetic Risk Associated with Social Anxiety

How to Ease Anxiety in Children

Can Depression and Anxiety Occur Together?

Agoraphobia Signs and Symptoms

Agoraphobia: Causes, Symptoms, Diagnosis & Treatment

Latest Anxiety News and Research

Sleep apnea more common in former football players than previously recognized

New research led by investigators at Vanderbilt Health and the Football Players Health Study at Harvard University suggests that sleep apnea may be far more common - and more clinically significant - among former professional football players than previously recognized.

22 Apr 2026

Bullying and social policies worsen mental health in gender-diverse teens

Gender-diverse adolescents who experience bullying and live in states with persistently unsupportive gender identity laws are significantly more likely to suffer escalating psychological distress compared to their peers, according to new research by UCLA Health.

21 Apr 2026

New guideline recommends combined therapies for chronic insomnia treatment

A new clinical practice guideline from the American Academy of Sleep Medicine provides evidence‑based recommendations on the combined use of behavioral‑psychological and pharmacological therapies to treat chronic insomnia disorder in adults.

21 Apr 2026

Calcium signals in microglia drive anxiety and compulsive behaviors

Researchers had previously discovered a population of immune cells within the brain that can act as accelerators and brakes for anxiety in mice. N

21 Apr 2026

Study links cognitive worries in Parkinson’s to anxiety and depression

For many individuals living with Parkinson's disease and those in its "prodromal" or early stages before movement impairment, there is a distressing gap between how they feel their brain is working and what clinical tests show.

21 Apr 2026

Gut microbiome clues may help spot Parkinson’s disease in its earliest phase

Researchers found that a Parkinson’s disease-related gut microbiome pattern appears not only in people with diagnosed Parkinson’s, but also in some non-manifesting GBA1 variant carriers and a subset of healthy individuals. The findings suggest that gut microbiome changes may help flag people who are closer to Parkinson’s disease development, although longitudinal studies are still needed to confirm predictive value.

21 Apr 2026

Coffee impacts the gut-brain axis to improve mood and stress

New research from APC Microbiome Ireland, a world leading research centre at University College Cork, has comprehensively explored the mechanisms behind coffee's positive effects on the gut-brain axis for the first time.

21 Apr 2026

Ibuprofen shown to improve cognitive function in patients undergoing chemotherapy

Researchers have already shown that mild to moderate exercise can reduce "chemo brain," and a new study suggests that a low dose of an over-the-counter anti-inflammatory, ibuprofen, can also achieve positive results for cancer patients.

21 Apr 2026

Brain organoids may guide Alzheimer’s diagnosis and treatment

Scientists from Johns Hopkins Medicine report new evidence that clusters of brain tissue derived from the cells of patients with Alzheimer's disease may be used to evaluate how certain patients with the neurodegenerative condition may respond to drugs commonly prescribed to treat psychiatric symptoms of the disorder.

20 Apr 2026

Serotonin may worsen tinnitus symptoms, mice study finds

The same neurotransmitter commonly leveraged to relieve symptoms of depression and anxiety also may exacerbate a vexing condition known as tinnitus, according to new research published in the Proceedings of the National Academy of Sciences.

20 Apr 2026

CBD shows promise, but this review warns the hype is outpacing the science

A Neuropsychopharmacology Circumspectives article argues that cannabidiol has genuine therapeutic potential, especially in treatment-resistant pediatric epilepsy, but evidence for most other uses remains limited, heterogeneous, and not yet mature enough for broad clinical adoption. The authors also warn that poor retail product quality, inaccurate labeling, contaminants, hepatotoxicity risk, and drug interactions are major barriers to safe and effective real-world use.

20 Apr 2026

An Arm and a Leg: The accidental architect of America’s drug patent problem

Depending on whom you ask, Alfred Engelberg could be a hero or a villain in the story of American pharmaceuticals.

20 Apr 2026

Your new therapist: Chatty, leaky, and hardly human

Vince Lahey of Carefree, Arizona, embraces chatbots. From Big Tech products to "shady" ones, they offer "someone that I could share more secrets with than my therapist."

17 Apr 2026

Women using GLP-1 drugs face higher weight loss stigma

In a new study exploring stigma associated with the use of GLP-1 drugs for weight loss, women who lost weight using GLP-1 medications were judged more harshly than those who lost weight through diet and exercise, with negative reactions driven largely by beliefs that medication-assisted weight loss is a "shortcut."

17 Apr 2026

UCL study urges clinician vigilance when prescribing gabapentinoids for pain

People who take gabapentinoids, a medication prescribed increasingly frequently worldwide, particularly for chronic pain, face a much greater risk of drug poisoning if they are also taking another medication, finds a new study by University College London (UCL) researchers.

17 Apr 2026